Blood cancer patients should continue BTKi therapy during COVID-19 vaccination
Source: News-Medical
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
The findings of a clinical trial led by the University of Birmingham and the Oxford Clinical Tr… [2981 chars]